Month: April 2021

LaunchPort’s Novel Microdevices Lands Important Funding from Carb-X Global Partnership

Novel Microdevices ( was awarded up to $13.8 million from CARB-X ( for the development of a rapid, point-of-care, molecular diagnostic platform for the detection of sexually transmitted diseases, including antibiotic-resistant infections such as Chlamydia trachomatis and Neisseria gonorrhoeae. Novel’s new device would diagnose infections in about 25 minutes from a vaginal swab or urine sample, and […]

Read More
Get Started

Let’s build something together.

The LaunchPort | Copyright 2020 | All rights reserved